VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 709 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $16,965 | +7.3% | 500 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $15,810 | +2.0% | 500 | 0.0% | 0.00% | -20.0% |
Q4 2023 | $15,505 | +15.2% | 500 | 0.0% | 0.01% | +25.0% |
Q3 2023 | $13,455 | -10.6% | 500 | 0.0% | 0.00% | -20.0% |
Q2 2023 | $15,055 | -6.9% | 500 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $16,175 | -94.6% | 500 | -95.2% | 0.01% | -94.7% |
Q4 2022 | $300,930 | +18.9% | 10,500 | 0.0% | 0.09% | +13.3% |
Q3 2022 | $253,000 | +1707.1% | 10,500 | +2000.0% | 0.08% | +1975.0% |
Q2 2022 | $14,000 | -26.3% | 500 | 0.0% | 0.00% | -20.0% |
Q1 2022 | $19,000 | -90.9% | 500 | -92.3% | 0.01% | -90.2% |
Q4 2021 | $208,000 | +28.4% | 6,500 | +18.2% | 0.05% | +13.3% |
Q3 2021 | $162,000 | +14.9% | 5,500 | +32.5% | 0.04% | +7.1% |
Q2 2021 | $141,000 | -15.6% | 4,150 | -19.4% | 0.04% | -20.8% |
Q1 2021 | $167,000 | +626.1% | 5,150 | +692.3% | 0.05% | +562.5% |
Q4 2020 | $23,000 | -37.8% | 650 | -67.5% | 0.01% | -42.9% |
Q3 2018 | $37,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |